Pancreatic Cancer Research

ResearcherKyushu UniversityNo recent work listed

Yoshitsugu Tajima

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7538-625X; OpenAlex author ID A5083990843, A5112549207. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
11
Papers, trials and grants by year

2012: 1 paper · 2013: 2 papers · 2014: none · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: 2 papers · 2019: none · 2020: 1 paper

Papers 9

  1. Laparoscopic versus open radical antegrade modular pancreatosplenectomy with artery-first approach in pancreatic cancer. Last author DOI 10.1007/s00423-020-01887-y↗
  2. Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis. Co-author DOI 10.1038/s41419-018-0851-z↗
  3. Chloroquine augments TRAIL-induced apoptosis and induces G2/M phase arrest in human pancreatic cancer cells. Co-author DOI 10.1371/journal.pone.0193990↗
  4. Modified total meso-pancreatoduodenum excision with pancreaticoduodenectomy as a mesopancreatic plane surgery in borderline resectable pancreatic cancer. Last author DOI 10.1016/j.ejso.2016.02.241↗
  5. Superior mesenteric artery-first approach in radical antegrade modular pancreatosplenectomy for borderline resectable pancreatic cancer: a technique to obtain … Last author DOI 10.1016/j.jamcollsurg.2014.12.054↗
  6. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL. Co-author DOI 10.18632/oncotarget.5881↗
  7. Attenuation of reactive oxygen species by antioxidants suppresses hypoxia-induced epithelial-mesenchymal transition and metastasis of pancreatic cancer cells. Co-author DOI 10.1007/s10585-012-9519-8↗
  8. The HSP70 and autophagy inhibitor pifithrin-μ enhances the antitumor effects of TRAIL on human pancreatic cancer. Co-author DOI 10.1158/1535-7163.mct-12-0954↗
  9. Low expression of nucleus accumbens-associated protein 1 predicts poor prognosis for patients with pancreatic ductal adenocarcinoma. Last author DOI 10.1111/pin.12020↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yasunari Kawabata · 5 shared papers, 2012–2020 · strength 0.41
  2. Mamoru Harada · 3 shared papers, 2013–2018 · strength 0.21
  3. Keizo Takenaga · 3 shared papers, 2012–2018 · strength 0.17
  4. Takeshi Nishi · 2 shared papers, 2012–2020 · strength 0.16
  5. Miho Akimoto · 2 shared papers, 2013–2018 · strength 0.15
  6. Hiroyuki Monma · 2 shared papers, 2013–2018 · strength 0.13
  7. Nanae Harashima · 2 shared papers, 2013–2015 · strength 0.12
  8. Yoko Hari · 1 shared paper, 2015 · strength 0.07
  9. Yoshihide Shimojo · 1 shared paper, 2013 · strength 0.04
  10. Seiji Yano · 1 shared paper, 2012 · strength 0.03
  11. Takeshi Urano · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.